Work

SUBDUE‐3: SUB‐urothelial DUrvalumab‐ 89 zirconium injEction; a phase 0 biodistribution study protocol

Year: 2026

Type: article

Source: British Journal of Urology

DOI: 10.1111/bju.70153

Authors: Kevin G. Keane, Richard Gauci, Roslyn J. Francis, Andrew M. Scott, Cynthia Hawks, Andrisha‐Jade Inderjeeth, Ian D. Davis, Jayne Lim, Andrew Redfern, Dickon Hayne

Institutions: The University of Western Australia, North Metropolitan Health Service, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, South Metropolitan Health Service, The University of Queensland, Royal Brisbane and Women's Hospital, Sir Charles Gairdner Hospital, La Trobe University, Olivia Newton-John Cancer Research Institute, Walter and Eliza Hall Institute of Medical Research, Eastern Health, Monash University, Harry Perkins Institute of Medical Research

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,770

OpenAlex ID: W7128719315

FWCI:

Cites: 9

Cited by:

Related to: